These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4539851)

  • 1. [Significance of the round forms of Trichomonas vaginalis].
    Ciucă T; Mihalache V
    Microbiol Parazitol Epidemiol (Bucur); 1972; 17(6):541-6. PubMed ID: 4539851
    [No Abstract]   [Full Text] [Related]  

  • 2. [Testing the effects of hydrazones and osazones of sugars on Trichomonas vaginalis (author's transl)].
    Demes P; Linek K; Nemogová E; Catár G; Klobusický M; Valent M
    Bratisl Lek Listy; 1982 Mar; 77(3):303-10. PubMed ID: 6978755
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitrichomonal strains of Bacillus thuringiensis.
    Kondo S; Mizuki E; Akao T; Ohba M
    Parasitol Res; 2002 Dec; 88(12):1090-2. PubMed ID: 12444461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of Cladonia alpestris on Trichomonas vaginalis in vitro].
    Wu J; Zhang M; Ding D; Tan T; Yan B
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):126-9. PubMed ID: 7554162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro sensitivity of 50 Trichomonas vaginalis strains to CP 12 574].
    Kremer M; Miltgen F; Dellenbach P
    Rev Fr Gynecol Obstet; 1972 Nov; 67(11):655-7. PubMed ID: 4540771
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-Trichomonas vaginalis activity of synthetic lipophilic diamine and amino alcohol derivatives.
    Giordani RB; De Almeida MV; Fernandes E; França da Costa C; De Carli GA; Tasca T; Zuanazzi JA
    Biomed Pharmacother; 2009 Sep; 63(8):613-7. PubMed ID: 19013752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro effect of secnidazole benzoate on Trichomonas vaginalis].
    Zhang XX; Zheng SS; Zhu MM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Apr; 27(2):111-4. PubMed ID: 19856497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the susceptibility of Candida albicans and Trichomonas vaginalis, on some products used as larvicides, trichomonacides and/or bactericides].
    Lacroix R; Reynouard F; Lacroix J; Combescot C
    Ann Pharm Fr; 1988; 46(3):205-9. PubMed ID: 3066257
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of Trichomonas vaginalis sensitivity to nitroimidazole group preparations using solid nutrient media].
    Bednova VN; Vasil'ev MM
    Vestn Dermatol Venerol; 1982 Nov; (11):19-21. PubMed ID: 6984259
    [No Abstract]   [Full Text] [Related]  

  • 10. [Criteria of clinical evaluation of antitrichomonal agents].
    Kurnatowska A
    Wiad Parazytol; 1979; 25(3):253-7. PubMed ID: 316618
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro effect of metronidazole ester on Trichomonas vaginalis and Entamoeba histolytica].
    He Y; Tao X; Guan L; Lian W
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(1):32-4. PubMed ID: 7788891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of a new nitroimidazole derivative (CP 12 574) on 67 strains of T. vaginalis.
    Miltgen F; Dellenbach P; Kremer M
    Wiad Parazytol; 1973; 19(3):499-501. PubMed ID: 4542510
    [No Abstract]   [Full Text] [Related]  

  • 13. [Physical-chemical properties and antitrichomonal effect of 2-, 4-, and 5-nitroimidazoles].
    Sunjić V; Kajfez F; Kolbah D; Blazević N
    Pharmazie; 1972 Mar; 27(3):131-8. PubMed ID: 4558978
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternative pathway of metronidazole activation in Trichomonas vaginalis hydrogenosomes.
    Hrdý I; Cammack R; Stopka P; Kulda J; Tachezy J
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5033-6. PubMed ID: 16304169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Trichomonacidal effect of new acridine derivatives].
    Kurnatowska A; Kadlubowski R
    Wiad Parazytol; 1973; 19(3):489-92. PubMed ID: 4542509
    [No Abstract]   [Full Text] [Related]  

  • 16. Trichomonas vaginalis: determination of acid phosphatase activity as a pharmacological screening procedure.
    Martínez-Grueiro MM; Montero-Pereira D; Giménez-Pardo C; Nogal-Ruiz JJ; Escario JA; Gómez-Barrio A
    J Parasitol; 2003 Oct; 89(5):1076-7. PubMed ID: 14627165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of Pimaricin as a trichomonacidal drug in in vitro experiments].
    Michalowski R; Zatorska H
    Wiad Parazytol; 1973; 19(3):503-4. PubMed ID: 4542511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the velocity of action of trichomonocidal drugs].
    Broccali G; De Carneri I
    Ginecol Obstet Mex; 1971 Nov; 30(181):481-90. PubMed ID: 5316160
    [No Abstract]   [Full Text] [Related]  

  • 19. [Disparaged leukorrhea and resistant forms of Trichomonas vaginalis].
    Hainaux H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):367-9. PubMed ID: 4549774
    [No Abstract]   [Full Text] [Related]  

  • 20. [The action of an aqueous extract of Aloe barbadensis Miller in an in-vitro culture of Trichomonas vaginalis].
    Rojas L; Matamoros M; Garrido N; Finlay C
    Rev Cubana Med Trop; 1995; 47(3):181-4. PubMed ID: 9813472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.